This inventor holds 3 USPTO granted patents. Top assignees: Novo Nordisk A/s, 501 Novo Industri A/s. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Janet M Overholt: Innovator in Bacteriolytic Enzyme Complexes
Introduction
Janet M Overholt is a distinguished inventor based in Danbury, CT (US). She has made significant contributions to the field of bacteriolytic enzymes, holding a total of 3 patents. Her work focuses on developing enzyme complexes that serve as antibacterial agents, showcasing her innovative spirit and dedication to scientific advancement.
Latest Patents
One of her latest patents involves the extraction of cell wall lytic enzymes from Bacillus pabuli. This bacteriolytic enzyme complex is derived from specific bacterial cultures and is effective against both Gram-positive and Gram-negative bacteria. The production process includes cultivating Bacillus pabuli microorganisms in an aqueous medium containing cornsteep liquor, followed by the recovery of the enzyme complex from the fermentation broth. Another notable patent features an enzyme complex that hydrolyzes bacterial cell walls, obtained from Nocardiopsis dassonvillei strains. This complex is produced by cultivating the microorganism in an aqueous medium with maltodextrin and soybean meal, making it useful as a detergent additive.
Career Highlights
Throughout her career, Janet has worked with prominent companies such as Novo Nordisk A/S and 501 Novo Industri A/S. Her experience in these organizations has allowed her to refine her expertise in enzyme technology and contribute to various innovative projects.
Collaborations
Janet has collaborated with notable colleagues, including Chi-Li Liu and Carol M Beck. These partnerships have further enriched her research and development efforts in the field of bacteriolytic enzymes.
Conclusion
Janet M Overholt's contributions to the development of bacteriolytic enzyme complexes highlight her innovative approach to solving complex scientific challenges. Her patents and collaborations reflect her commitment to advancing antibacterial technologies.